Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases

Fortunato Morabito, Tait D. Shanafelt, Massimo Gentile, Gianluigi Reda, Francesca Romana Mauro, Davide Rossi, Nicola Di Renzo, Stefano Molica, Francesco Angrilli, Annalisa Chiarenza, Giovanna Cutrona, Kari G. Chaffee, Sameer A. Parikh, Giovanni Tripepi, Graziella D'Arrigo, Ernesto Vigna, Anna Grazia Recchia, Agostino Cortelezzi, Gianluca Gaidano, Francesco Di RaimondoFranco Fais, Robin Foà, Antonino Neri, Manlio Ferrarini

Research output: Contribution to journalLetter

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)E216-E219
JournalAmerican journal of hematology
Volume93
Issue number9
DOIs
StatePublished - Sep 2018

ASJC Scopus subject areas

  • Hematology

Cite this

Morabito, F., Shanafelt, T. D., Gentile, M., Reda, G., Mauro, F. R., Rossi, D., Di Renzo, N., Molica, S., Angrilli, F., Chiarenza, A., Cutrona, G., Chaffee, K. G., Parikh, S. A., Tripepi, G., D'Arrigo, G., Vigna, E., Recchia, A. G., Cortelezzi, A., Gaidano, G., ... Ferrarini, M. (2018). Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases. American journal of hematology, 93(9), E216-E219. https://doi.org/10.1002/ajh.25206